logo
Share SHARE
FONT-SIZE Plus   Neg

Dr. Reddy's Launches Zenatane In US Market - Quick Facts

Dr. Reddy's Laboratories (RDY: Quote) announced it has launched Zenatane in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane, in the US market on March 28, 2013 following the approval by the FDA of ANDA for Zenatane 10 mg, 20 mg and 40 mg.

The company noted that total market had U.S. sales of approximately $309 million for the most recent twelve months ending January 2013 according to IMS Health.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fox News pundit Bill O'Reilly remains under fire amid accusations that he trumped up his role in covering international events. Only weeks after a Mother Jones article raised doubts about his claims that he was in the "warzone" during the Falklands War, the Washington Post noticed that O'Reilly once... PayPal, the online payment unit of Ebay, said it has agreed to buy mobile payment company Paydiant as part of efforts to expand its mobile offerings for merchants. The deal comes at a time when the mobile payment space is suffused with prominent players like Apple and Google, with retailers seeking their own mobile payment applications. Google plans to launch a limited-scale U.S. wireless service, which while not taking on the big players in the industry, would nonetheless incorporate technical innovations that could be absorbed the carriers. This was announced by Sundar Pichai, a top Google executive, at the ongoing World Mobile Congress in Barcelona.
comments powered by Disqus
Follow RTT